ARCH Venture Fund IX, L.P. 13D/13G Filings for Karuna Therapeutics, Inc. (KRTX)

ARCH Venture Fund IX, L.P. 13D and 13G filings for Karuna Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-09-20
4:58 pm
Sale
2022-08-1213DKARUNA THERAPEUTICS INC
KRTX
ARCH Venture Fund IX, L.P.0
0.000%
-2,946,891decrease
(Position Closed)
Filing